
M K Medipharmaceuticals Private Limited
Produces and distributes pharmaceutical and chemical products for various medical branches.
Produces and distributes pharmaceutical and chemical products for various medical branches.
M K Medipharmaceuticals Private Limited (MKMPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 August 2012 and has a history of 12 years and six months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Chaudhary and Rajnish Kumar serve as directors at the Company.
Jaipur, Rajasthan, India
+91-XXXXXXXXXX
-
U24232RJ2012PTC039878
039878
Private Limited Indian Non-Government Company
24 Aug 2012
30 Sep 2023
31 Mar 2023
Unlisted
Roc Jaipur
M K Medipharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Common Disease Medicines, Skin Lightening Drugs, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Cardiovascular Drugs & Medication, Immunosuppressive Drugs, Antihistamines, Antiepileptic Drugs.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Chaudhary ![]() | Director | 16-Jan-2017 | Current |
Rajnish Kumar ![]() | Director | 26-Dec-2018 | Current |
M K Medipharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.21% increase. The company also saw a slight improvement in profitability, with a 0.6% increase in profit. The company's net worth moved up by a moderate rise of 4.79%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, M K Medipharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sunil Chaudhary is a mutual person
Sunil Chaudhary is a mutual person
Sunil Chaudhary is a mutual person
Sunil Chaudhary is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with M K Medipharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of M K Medipharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M K Medipharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
M K Medipharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
M K Medipharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Jaipur.
Rajnish Shrivastav Kumar was appointed as a Director was appointed as a Director on 26 Dec 2018 & has been associated with this company since 6 years 2 months .
Sunil Chaudhary was appointed as a Director was appointed as a Director on 16 Jan 2017 & has been associated with this company since 8 years 1 month .
M K Medipharmaceuticals Private Limited was registered on 24 Aug 2012 with Roc Jaipur & aged 12 years 6 months as per MCA records.
M K Medipharmaceuticals Private Limited was incorporated on 24 Aug 2012.
The authorized share capital of M K Medipharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with M K Medipharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of M K Medipharmaceuticals Private Limited is M.B. 42 Ground Floor Scheme No.8 Everest Vihar Brij Lalpura, Jaipur, Rajasthan, India, 302019.
The corporate identification number (CIN) of M K Medipharmaceuticals Private Limited is U24232RJ2012PTC039878 and the company number is 039878 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for M K Medipharmaceuticals Private Limited has risen by 13.21%.
The financial reports for the fiscal year 2023 indicates that The net worth of M K Medipharmaceuticals Private Limited has experienced an upsurge of 4.79%.
The most recent Balance Sheet for M K Medipharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
VG
K
UK